Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 2Other hematologic neoplasm 1Dermatologic 1

Conditions

Melanoma 22Neoplasm Metastasis 2Uveal Melanoma 1Skin Neoplasms 1Neoplasms 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Carcinoma, Renal Cell 1

Interventions

Peripheral Blood Stem Cell Transplantation 38fludarabine phosphate 34Cyclophosphamide 30Mycophenolic Acid 25Whole-Body Irradiation 22Cyclosporine 22Tacrolimus 21Busulfan 18Methotrexate 17Antilymphocyte Serum 16Radiotherapy 14Flow Cytometry 13Filgrastim 13Etoposide 13Vorinostat 10Methylprednisolone 10Bortezomib 10Bexarotene 10Melphalan 9Therapeutics 8Rituximab 8Psychiatric Rehabilitation 8Polymerase Chain Reaction 8Lenalidomide 8Gemcitabine 8romidepsin 7fludarabine 6Cord Blood Stem Cell Transplantation 6Brentuximab Vedotin 6tanespimycin 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mycosis Fungoides × Interferon alpha-2 × Dermatologic × Clear all
NCT02323659 2022-01-13

Comparison of Methotrexate Versus Interferon-alfa 2b in Patients With Primary Cutaneous T-cell Lymphomas

Polish Lymphoma Research Group

Phase 4 Terminated
100 enrolled
DermatologicLymphoid

Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡